{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T17:39:17Z","timestamp":1793813957130,"version":"4.6.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/100005205","name":"Janssen Research and Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005205","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Merck-Schering-Plough"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s13075-016-1200-1","type":"journal-article","created":{"date-parts":[[2016,12,28]],"date-time":"2016-12-28T05:48:35Z","timestamp":1482904115000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":37,"title":["Serum biomarkers and changes in clinical\/MRI evidence of golimumab-treated patients with ankylosing spondylitis: results of the randomized, placebo-controlled GO-RAISE study"],"prefix":"10.1186","volume":"18","author":[{"given":"Robert D.","family":"Inman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xenofon","family":"Baraliakos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kay-Geert A.","family":"Hermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00fcrgen","family":"Braun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atul","family":"Deodhar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D\u00e9sir\u00e9e","family":"van der Heijde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,12,28]]},"reference":[{"key":"1200_CR1","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1002\/art.21790","volume":"54","author":"J Braun","year":"2006","unstructured":"Braun J, Landew\u00e9 R, Hermann KG, Han J, Yan S, Williamson P, et al. Major reduction in spinal inflammation in patients with ankylosing spondylitis after treatment with infliximab: results of a multicenter, randomized, double-blind, placebo-controlled magnetic resonance imaging study. Arthritis Rheum. 2006;54:1646\u201352.","journal-title":"Arthritis Rheum."},{"key":"1200_CR2","doi-asserted-by":"crossref","first-page":"4005","DOI":"10.1002\/art.23044","volume":"56","author":"RG Lambert","year":"2007","unstructured":"Lambert RG, Salonen D, Rahman P, Inman RD, Wong RL, Einstein SG, et al. Adalimumab significantly reduces both spinal and sacroiliac joint inflammation in patients with ankylosing spondylitis: a multicenter, randomized, double-blind, placebo-controlled study. Arthritis Rheum. 2007;56:4005\u201314.","journal-title":"Arthritis Rheum."},{"key":"1200_CR3","doi-asserted-by":"crossref","first-page":"3402","DOI":"10.1002\/art.23969","volume":"58","author":"RD Inman","year":"2008","unstructured":"Inman RD, Davis Jr JC, van der Heijde D, Diekman L, Sieper J, Kim SI, et al. Efficacy and safety of golimumab in patients with ankylosing spondylitis: results of a randomized, double-blind, placebo-controlled, phase III trial. Arthritis Rheum. 2008;58:3402\u201312.","journal-title":"Arthritis Rheum."},{"key":"1200_CR4","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1136\/ard.2011.154799","volume":"71","author":"J Braun","year":"2012","unstructured":"Braun J, Deodhar A, Inman RD, van der Heijde D, Mack M, Xu S, et al. Golimumab administered subcutaneously every 4\u00a0weeks in ankylosing spondylitis: 104-week results of the GO-RAISE study. Ann Rheum Dis. 2012;71:661\u20137.","journal-title":"Ann Rheum Dis."},{"key":"1200_CR5","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1136\/annrheumdis-2011-200308","volume":"71","author":"J Braun","year":"2012","unstructured":"Braun J, Baraliakos X, Hermann KG, van der Heijde D, Inman RD, Deodhar AA, et al. Golimumab reduces spinal inflammation in ankylosing spondylitis: MRI results of the randomised, placebo-controlled GO-RAISE study. Ann Rheum Dis. 2012;71:878\u201384.","journal-title":"Ann Rheum Dis."},{"key":"1200_CR6","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1002\/art.38070","volume":"65","author":"N Haroon","year":"2013","unstructured":"Haroon N, Inman RD, Learch TJ, Weisman MH, Lee M, Rahbar MH, et al. The impact of tumor necrosis factor inhibitors on radiographic progression in ankylosing spondylitis. Arthritis Rheum. 2013;65:2645\u201354.","journal-title":"Arthritis Rheum."},{"key":"1200_CR7","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1136\/annrheumdis-2014-205178","volume":"73","author":"S Ramiro","year":"2014","unstructured":"Ramiro S, van der Heijde D, van Tubergen A, Stolwijk C, Dougados M, van den Bosch F, et al. Higher disease activity leads to more structural damage in the spine in ankylosing spondylitis: 12-year longitudinal data from the OASIS cohort. Ann Rheum Dis. 2014;73:1455\u201361.","journal-title":"Ann Rheum Dis."},{"key":"1200_CR8","doi-asserted-by":"crossref","first-page":"R104","DOI":"10.1186\/ar2496","volume":"10","author":"X Baraliakos","year":"2008","unstructured":"Baraliakos X, Listing J, Rudwaleit M, Sieper J, Braun J. The relationship between inflammation and new bone formation in patients with ankylosing spondylitis. Arthritis Res Ther. 2008;10:R104.","journal-title":"Arthritis Res Ther."},{"key":"1200_CR9","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1002\/art.24132","volume":"60","author":"WP Maksymowych","year":"2009","unstructured":"Maksymowych WP, Chiowchanwisawakit P, Clare T, Pedersen SJ, \u00d8stergaard M, Lambert RG. Inflammatory lesions of the spine on magnetic resonance imaging predict the development of new syndesmophytes in ankylosing spondylitis: evidence of a relationship between inflammation and new bone formation. Arthritis Rheum. 2009;60:93\u2013102.","journal-title":"Arthritis Rheum."},{"key":"1200_CR10","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1136\/ard.2009.110767","volume":"68","author":"M Rudwaleit","year":"2009","unstructured":"Rudwaleit M, Jurik AG, Hermann KG, Landew\u00e9 R, van der Heijde D, Baraliakos X, et al. Defining active sacroiliitis on magnetic resonance imaging (MRI) for classification of axial spondyloarthritis: a consensual approach by the ASAS\/OMERACT MRI group. Ann Rheum Dis. 2009;68:1520\u20137.","journal-title":"Ann Rheum Dis."},{"key":"1200_CR11","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1136\/annrheumdis-2011-200208","volume":"71","author":"D Heijde van der","year":"2012","unstructured":"van der Heijde D, Machado P, Braun J, Hermann KG, Baraliakos X, Hsu B, et al. MRI inflammation at the vertebral unit only marginally predicts new syndesmophyte formation: a multilevel analysis in patients with ankylosing spondylitis. Ann Rheum Dis. 2012;71:369\u201373.","journal-title":"Ann Rheum Dis."},{"key":"1200_CR12","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1136\/ard.2010.148890","volume":"71","author":"C Wagner","year":"2012","unstructured":"Wagner C, Visvanathan S, Braun J, van der Heijde D, Deodhar A, Hsu B, et al. Serum markers associated with clinical improvement in patients with ankylosing spondylitis treated with golimumab. Ann Rheum Dis. 2012;71:674\u201380.","journal-title":"Ann Rheum Dis."},{"key":"1200_CR13","first-page":"2286","volume":"21","author":"S Garrett","year":"1994","unstructured":"Garrett S, Jenkinson T, Kennedy LG, Whitelock H, Gaisford P, Calin A. A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index. J Rheumatol. 1994;21:2286\u201391.","journal-title":"J Rheumatol."},{"key":"1200_CR14","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1136\/ard.2008.100826","volume":"68","author":"D Heijde van der","year":"2009","unstructured":"van der Heijde D, Lie E, Kvien TK, Sieper J, Van den Bosch F, Listing J, et al. ASDAS, a highly discriminatory ASAS-endorsed disease activity score in patients with ankylosing spondylitis. Ann Rheum Dis. 2009;68:1811\u20138.","journal-title":"Ann Rheum Dis."},{"key":"1200_CR15","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1002\/art.10883","volume":"48","author":"J Braun","year":"2003","unstructured":"Braun J, Baraliakos X, Golder W, Brandt J, Rudwaleit M, Listing J, et al. Magnetic resonance imaging examinations of the spine in patients with ankylosing spondylitis, before and after successful therapy with infliximab: evaluation of a new scoring system. Arthritis Rheum. 2003;48:1126\u201336.","journal-title":"Arthritis Rheum."},{"key":"1200_CR16","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1136\/ard.2004.029298","volume":"64","author":"X Baraliakos","year":"2005","unstructured":"Baraliakos X, Landew\u00e9 R, Hermann KG, Listing J, Golder W, Brandt J, et al. Inflammation in ankylosing spondylitis: a systematic description of the extent and frequency of acute spinal changes using magnetic resonance imaging. Ann Rheum Dis. 2005;64:730\u20134.","journal-title":"Ann Rheum Dis."},{"key":"1200_CR17","first-page":"127","volume":"64","author":"MCW Creemers","year":"2005","unstructured":"Creemers MCW. Franssen MJAM, van \u2019t Hof MA, Gribnau FWJ, van de Putte LBA, van Riel PLCM. Assessment of outcome in ankylosing spondylitis: an extended radiographic scoring system Ann Rheum Dis. 2005;64:127\u20139.","journal-title":"Assessment of outcome in ankylosing spondylitis: an extended radiographic scoring system. Ann Rheum Dis."},{"key":"1200_CR18","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1136\/annrheumdis-2012-203075","volume":"73","author":"J Braun","year":"2014","unstructured":"Braun J, Baraliakos X, Hermann KG, Deodhar A, van der Heijde D, Inman R, et al. The effect of two golimumab doses on radiographic progression in ankylosing spondylitis: results through 4\u00a0years of the GO-RAISE trial. Ann Rheum Dis. 2014;73:1107\u201313.","journal-title":"Ann Rheum Dis."},{"key":"1200_CR19","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1002\/art.30393","volume":"63","author":"P Chiowchanwisawakit","year":"2011","unstructured":"Chiowchanwisawakit P, Lambert RG, Conner-Spady B, Maksymowych WP. Focal fat lesions at vertebral corners on magnetic resonance imaging predict the development of new syndesmophytes in ankylosing spondylitis. Arthritis Rheum. 2011;63:2215\u201325.","journal-title":"Arthritis Rheum."},{"key":"1200_CR20","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1136\/annrheumdis-2013-203425","volume":"73","author":"X Baraliakos","year":"2014","unstructured":"Baraliakos X, Heldmann F, Callhoff J, Listing J, Appelboom T, Brandt J, et al. Which spinal lesions are associated with new bone formation in patients with ankylosing spondylitis treated with anti-TNF agents? A long-term observational study using MRI and conventional radiography. Ann Rheum Dis. 2014;73:1819\u201325.","journal-title":"Ann Rheum Dis."},{"key":"1200_CR21","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0005-2736(02)00686-7","volume":"1609","author":"K Cianflone","year":"2003","unstructured":"Cianflone K, Xia Z, Chen LY. Critical review of acylation-stimulating protein physiology in humans and rodents. Biochim Biophys Acta. 2003;1609:127\u201343.","journal-title":"Biochim Biophys Acta."},{"key":"1200_CR22","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1139\/o06-207","volume":"85","author":"R MacLaren","year":"2007","unstructured":"MacLaren R, Kalant D, Cianflone K. The ASP receptor C5L2 is regulated by metabolic hormones associated with insulin resistance. Biochem Cell Biol. 2007;85:11\u201321.","journal-title":"Biochem Cell Biol."},{"key":"1200_CR23","first-page":"201","volume":"28","author":"T Li","year":"2010","unstructured":"Li T, Huang Z, Zheng B, Liao Z, Zhao L, Gu J. Serum disease-associated proteins of ankylosing spondylitis: results of a preliminary study by comparative proteomics. Clin Exp Rheumatol. 2010;28:201\u20137.","journal-title":"Clin Exp Rheumatol."},{"key":"1200_CR24","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/j.1749-6632.2009.05289.x","volume":"1193","author":"JR Kirwan","year":"2010","unstructured":"Kirwan JR, Clarke L, Hunt LP, Perry MG, Straub RH, Jessop DS. Effect of novel therapeutic glucocorticoids on circadian rhythms of hormones and cytokines in rheumatoid arthritis. Ann N Y Acad Sci. 2010;1193:127\u201333.","journal-title":"Ann N Y Acad Sci."},{"issue":"Suppl 2","key":"1200_CR25","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1186\/ar4687","volume":"16","author":"CM Spies","year":"2014","unstructured":"Spies CM, Straub RH, Cutolo M, Buttgereit F. Circadian rhythms in rheumatology - a glucocorticoid perspective. Arthritis Res Ther. 2014;16 Suppl 2:S3.","journal-title":"Arthritis Res Ther"},{"key":"1200_CR26","doi-asserted-by":"crossref","first-page":"3121","DOI":"10.2337\/db14-0796","volume":"64","author":"V Pellegrinelli","year":"2015","unstructured":"Pellegrinelli V, Rouault C, Rodriguez-Cuenca S, Albert V, Edom-Vovard F, Vidal-Puig A, et al. Human adipocytes induce inflammation and atrophy in muscle cells during obesity. Diabetes. 2015;64:3121\u201334.","journal-title":"Diabetes."}],"container-title":["Arthritis Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-016-1200-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,21]],"date-time":"2024-06-21T09:17:03Z","timestamp":1718961423000},"score":1,"resource":{"primary":{"URL":"http:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/s13075-016-1200-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["1200"],"URL":"https:\/\/doi.org\/10.1186\/s13075-016-1200-1","relation":{},"ISSN":["1478-6362"],"issn-type":[{"value":"1478-6362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,12]]},"article-number":"304"}}